Sort
23,748 grants matching “melanoma”
Tpl2 in Carcinogenesis-Related Inflammation
$380,871Kathleen Leigh Decicco-Skinner · American University · UA5 · FY2011 · CA
A Novel Symbiotic Approach for Ovarian Cancer
$380,835Jogender Tushir-Singh · University Of California At Davis · R01 · FY2023 · CA
Highly-Integrated Ultrasmall and Bright Fluorescent Silica Particle Architectures
$380,767Ulrich Wiesner · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA
GENE EXPRESSION PROFILING OF UNKNOWN PRIMARY CANCERS
$380,741Stanford University · R33 · FY2003 · CA
THE GENETICS OF OCULAR MELANOMA
$380,739Anne Mary Bowcock · Imperial College Of Science, Technology And Medicine · R01 · FY2014 · CA
Targeting apoptosis via chemical design of Bcl-2 antagonists
$380,712Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA
Highly-Integrated Ultrasmall and Bright Fluorescent Silica Particle Architectures
$380,695Ulrich Wiesner · Sloan-Kettering Inst Can Research · U54 · FY2018 · CA
Core C: Patient Derived Xenograft (PDX)/ Syngeneic Mouse Core
$380,670Gatien Moriceau · University Of California Los Angeles · P01 · FY2022 · CA
Core C: Patient Derived Xenograft (PDX)/ Syngeneic Mouse Core
$380,670Gatien Moriceau · University Of California Los Angeles · P01 · FY2023 · CA
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
$380,627Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2021 · CA
GMPS-GMPR axis melanoma progression and therapy
$380,624Mikhail Nikiforov · Wake Forest University Health Sciences · R01 · FY2019 · CA
CANCER AND LEUKEMIA GROUP B
$380,576University Of Chicago · U10 · FY2002 · CA
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
$380,517Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2020 · CA
Mechanisms of liver metastasis and associated resistance to immunotherapy
$380,509Benjamin Izar · Columbia University Health Sciences · R37 · FY2021 · CA
Discovery and Clinical Validation of Cancer Biomarkers Using Printed Glycan Array
$380,370Margaret Elisabeth Huflejt · New York University School Of Medicine · U01 · FY2008 · CA
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors
$380,325Ann Richmond · Vanderbilt University · R01 · FY2023 · CA
Penn Small Animal Imaging Resource (Penn-SAIR)
$380,325Jerry D Glickson · University Of Pennsylvania · U24 · FY2007 · CA
Coordinated Cytoskeletal Dynamics and Membrane Remodeling in Cellular Shape Change
$380,281Stephanie Gupton · Univ Of North Carolina Chapel Hill · R35 · FY2023 · GM
Coordinated Cytoskeletal Dynamics and Membrane Remodeling in Cellular Shape Change
$380,281Stephanie Gupton · Univ Of North Carolina Chapel Hill · R35 · FY2022 · GM
Coordinated Cytoskeletal Dynamics and Membrane Remodeling in Cellular Shape Change
$380,281Stephanie Gupton · Univ Of North Carolina Chapel Hill · R35 · FY2020 · GM
Coordinated Cytoskeletal Dynamics and Membrane Remodeling in Cellular Shape Change
$380,281Stephanie Gupton · Univ Of North Carolina Chapel Hill · R35 · FY2021 · GM
Coordinated Cytoskeletal Dynamics and Membrane Remodeling in Cellular Shape Change
$380,281Stephanie Gupton · Univ Of North Carolina Chapel Hill · R35 · FY2024 · GM
The regulation of melanocyte stem cells by Wnt signaling
$380,250Mayumi Ito · New York University School Of Medicine · R01 · FY2011 · AR
The regulation of melanocyte stem cells by Wnt signaling
$380,250Mayumi Ito · New York University School Of Medicine · R01 · FY2015 · AR
Biogenesis of Melanosomes
$380,250Seth J. Orlow · New York University School Of Medicine · R01 · FY2016 · AR